Annual Drug Patent Expirations for ISTODAX
Istodax is a drug marketed by Celgene and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ISTODAX.
This drug has five patent family members in five countries.
The generic ingredient in ISTODAX is romidepsin. Two suppliers are listed for this compound. Additional details are available on the romidepsin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com